Streetbeat News

Revenues

TVTX

Travere Therapeutics (NASDAQ:TVTX) has been analyzed by 6 analysts, showing a mix of bullish to bearish sentiments. Recent ratings indicate a shift towards a more positive outlook, with an average 12-month price target of $13.33, up from $12.20. The company, focusing on rare kidney, liver, and metabolic diseases, shows a positive revenue trend with a 53.58% growth rate as of December 31, 2023, but faces challenges with a high debt-to-equity ratio of 2.02 and below-average ROE and ROA.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 2:00 pm

VCIG

VCI Global Limited (NASDAQ:VCIG) announced its strategic expansion by opening offices in New York and London and setting up an AI R&D Center in Frankfurt. This move aims to accelerate revenue growth and advance AI innovations. The New York and London offices will be led by Marco Baccanello, a Corporate Finance and Private Equity executive with experience in technology sector transactions. The Frankfurt AI R&D Center will be headed by Pascal Lauria, a veteran in AI and machine learning, aiming to nurture potential unicorn businesses.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 1:19 pm

LRHC

La Rosa Holdings Corp. (LRHC) is on track to achieve its goal of generating $100M in annualized revenue by the end of 2024, through acquisitions and integration of franchisees and ancillary services companies. The company anticipates becoming profitable at the start of 2025.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 1:18 pm

MGIC

Magic Software Enterprises Ltd (NASDAQ:MGIC) reported Q4 revenue of $125.5 million, surpassing the consensus of $117.5 million, with a 14.7% year-on-year decline. Adjusted EPS was $0.24, beating the consensus of $0.19. The company saw an expansion in adjusted gross margin to 30.8% and operating margin to 14.1%. Cash and equivalents stood at $107.1 million as of December 31, 2023. Operating cash flow for the year was $77.9 million, up from $56.6 million Y/Y. CEO Guy Bernstein remains positive despite a slowdown in the second half of the year. Magic Software introduced a 2024 revenue guidance of $540-$550 million, well above the consensus of $473.77 million. MGIC shares rose 6.92% to $11.43 in premarket trading.

Portfolio Pulse from Anusuya Lahiri

March 13, 2024 | 1:13 pm

BTCUSD

NYCB

This week, Jerome Powell's dovish stance before Congress, weaker job reports, all-time highs for Bitcoin and gold, rising gas and oil prices due to production cuts, and the investor bailout of New York Community Bank ($NYCB) were highlighted. Powell's willingness to lower rates before inflation hits 2% mirrors past mistakes, while job data suggests a weaker economy than reported. Bitcoin and gold reaching all-time highs indicate a search for stability amidst market volatility. Saudi Arabia and Russia's production cuts have pushed oil prices over $80. The $1 billion investment led by Steve Mnuchin in NYCB reflects ongoing concerns about the banking sector's stability.

Portfolio Pulse from Gary Brode

March 13, 2024 | 1:12 pm

LRHC

La Rosa has acquired a 51% interest in its eighth franchisee since its IPO, aiming to achieve a $100 million annualized revenue target by the end of 2024. The terms of the acquisition were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 1:09 pm

NURO

NeuroMetrix, Inc. (NASDAQ:NURO) announced that over 2000 fibromyalgia patients have been prescribed its Quell Fibromyalgia device since its launch in December 2022. The device, a TENS unit for fibromyalgia symptom reduction, has received positive feedback from healthcare providers. It is prescription-only, in line with FDA regulations, and can be used during sleep.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 1:08 pm

WSM

Williams-Sonoma projects mid-to-high single-digit annual net revenue growth and an operating margin in the mid-to-high teens over the long term.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 1:04 pm

WSM

Williams-Sonoma forecasts FY24 revenue growth between -3% to +3% and comparable sales ranging from -4.5% to +1.5%. The company anticipates an operating margin of 16.5% to 16.8%, factoring in the impact of a 53-week fiscal year. This additional week is expected to contribute 150bps to revenue growth and 10bps to operating margin. Long-term, Williams-Sonoma aims for mid-to-high single-digit annual net revenue growth with an operating margin in the mid-to-high teens.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 1:03 pm

MP

MP Materials (NYSE:MP) has been evaluated by 4 analysts over the last three months, showing a shift from bullish to more cautious ratings. The average 12-month price target for MP has dropped 18.59% to $20.62. Analysts from Morgan Stanley, B of A Securities, and JP Morgan have adjusted their ratings and price targets, reflecting changes in market conditions and company performance. MP Materials, a producer of rare earth materials, faces financial challenges with a significant revenue decline of -55.81% and a net margin of -39.46%, despite a strong ROE and ROA.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 1:01 pm